Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.

@article{Raney2008ResultsIP,
  title={Results in patients with cranial parameningeal sarcoma and metastases (Stage 4) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV, 1978-1997: report from the Children's Oncology Group.},
  author={Beverly Raney and James R. Anderson and John Breneman and Sarah S. Donaldson and Winston W Huh and Harold M. Maurer and Jeff Michael Michalski and Stephen J. Qualman and Fred A. Ullrich and Moody D. Wharam and William Meyer},
  journal={Pediatric blood & cancer},
  year={2008},
  volume={51 1},
  pages={17-22}
}
PURPOSE Determine outcome of patients with cranial parameningeal sarcoma and concurrent metastases treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols II-IV. PATIENTS We identified 91 patients in the database, which includes newly diagnosed subjects <21 years old with rhabdomyosarcoma (RMS) and undifferentiated sarcoma, and reviewed their charts in detail. RESULTS The 54 males and 37 females were <1-19 years at diagnosis. Primary sites were nasopharynx-nasal cavity, middle… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2001
View 2 Excerpts

Similar Papers

Loading similar papers…